Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.71 |
| ▸ | RAB9A | P51151 | 5/20 | 0.71 |
| ▸ | NPC1 | O15118 | 4/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.71 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.71 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.71 |
| ▸ | MAPT | P10636 | 2/20 | 0.68 |
| ▸ | HPGD | P15428 | 1/20 | 0.68 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.68 |
| ▸ | MEN1 | O00255 | 3/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.66 |
| ▸ | TP53 | P04637 | 1/20 | 0.66 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.66 |
| ▸ | BLM | P54132 | 1/20 | 0.66 |
| ▸ | MLYCD | O95822 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30014222 | 0.88 | RAB9A (0.83) | GAASMN1; SMN2RAB9ANPC1ALDH1A1 | |
| SCHEMBL25681592 | 0.85 | GAA (1.00) | GAASMN1; SMN2RAB9ANPC1ALDH1A1 | |
| SCHEMBL31637520 | 0.84 | RAB9A (0.96) | GAASMN1; SMN2RAB9ANPC1ALDH1A1 | |
| SCHEMBL28733081 | 0.84 | ALDH1A1 (0.58) | GAASMN1; SMN2RAB9ANPC1ALDH1A1 | |
| SCHEMBL8769380 | 0.83 | GAA (0.73) | GAASMN1; SMN2RAB9ANPC1ALDH1A1 | |
| SCHEMBL10594359 | 0.83 | GAA (0.73) | GAASMN1; SMN2RAB9ANPC1CYP2C9 | |
| SCHEMBL20236734 | 0.83 | SMN1; SMN2 (1.00) | GAASMN1; SMN2RAB9ANPC1CYP2C9 | |
| SCHEMBL5852053 | 0.83 | GAA (0.73) | GAASMN1; SMN2RAB9ANPC1ALDH1A1 | |
| SCHEMBL5852049 | 0.83 | GAA (0.73) | GAASMN1; SMN2RAB9ANPC1ALDH1A1 | |
| SCHEMBL2475796 | 0.83 | GAA (0.73) | GAASMN1; SMN2RAB9ANPC1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1429607-B1 | DELTA 1-PYRROLINES USED AS PESTICIDES | BAYER CROPSCIENCE AG (DE) | 2007-04-04 | — | — | EP | disclosed |
| US-7074785-B2 | Δ1-pyrrolines used as pesticides | BAYER CROPSCIENCE AG (DE) | 2006-07-11 | — | — | US | disclosed |
| US-20060142369-A1 | Delta 1-pyrrolines used as pesticides | SEITZ THOMAS | 2006-06-29 | — | — | US | disclosed |
| US-20050014650-A1 | Delta 1-pyrrolines used as pesticides | BAYER CROPSCIENCE AG (DE) | 2005-01-20 | — | — | US | disclosed |
| EP-1429607-A1 | DELTA 1-PYRROLINES USED AS PESTICIDES | Bayer CropScience AG (DE) | 2004-06-23 | — | — | EP | disclosed |
| WO-2003024220-A1 | DELTA 1-PYRROLINES USED AS PESTICIDES | BAYER CROPSCIENCE AG (DE) | 2003-03-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060142369-A1 | Delta 1-pyrrolines used as pesticides | DDT, CHRM1, OPRD1 | GAA 3835/4885SMN1; SMN2 2977/4885RAB9A 562/4885 |
| US-20050014650-A1 | Delta 1-pyrrolines used as pesticides | CHRM1, DDT, CHRND | GAA 3965/4885SMN1; SMN2 2621/4885RAB9A 664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.